Published in Public Health Ethics on March 14, 2016
The inverse care law. Lancet (1971) 37.77
Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA (2014) 6.42
Impure science: AIDS, activism, and the politics of knowledge. Med Soc (Berkeley) (1996) 6.02
Socioeconomic status and smoking: a review. Ann N Y Acad Sci (2011) 4.11
Stigma and the ethics of public health: not can we but should we. Soc Sci Med (2008) 4.00
Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence. Nicotine Tob Res (2011) 3.25
The global research neglect of unassisted smoking cessation: causes and consequences. PLoS Med (2010) 2.75
Explaining the social gradient in smoking cessation: it's not in the trying, but in the succeeding. Tob Control (2008) 2.48
Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic. Clin Pharmacol Ther (2011) 2.33
Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev (2012) 2.17
Immunotherapy for the treatment of drug abuse. Pharmacol Ther (2005) 2.11
Should smokers be offered assistance with stopping? Addiction (2010) 2.07
Tobacco control policies specified according to socioeconomic status: health disparities and cost-effectiveness. Nicotine Tob Res (2014) 2.03
Ethics and governance of global health inequalities. J Epidemiol Community Health (2006) 1.83
Impact of tobacco control interventions on socioeconomic inequalities in smoking: review of the evidence. Tob Control (2013) 1.82
Nicotine conjugate vaccine: is there a right to a smoking future? J Med Ethics (2004) 1.79
Medicalization and pharmaceuticalization at the intersections: Looking backward, sideways and forward. Soc Sci Med (2012) 1.67
Clinical trials as treatment option: bioethics and health care disparities in substance dependency. Soc Sci Med (2009) 1.66
'Real-world' effectiveness of smoking cessation treatments: a population study. Addiction (2013) 1.60
The birth of the empirical turn in bioethics. Bioethics (2005) 1.52
The smoking population in the USA and EU is softening not hardening. Tob Control (2015) 1.51
Health, vital goals, and central human capabilities. Bioethics (2012) 1.42
Therapeutic advances in the treatment of nicotine addiction: present and future. Ther Adv Chronic Dis (2010) 1.42
Preventing sin: the ethics of vaccines against smoking. Hastings Cent Rep (2013) 1.41
Pharmacological treatments for smoking cessation. JAMA (2014) 1.39
Smoking and inequalities. Lancet (2006) 1.30
The social context of smoking: A qualitative study comparing smokers of high versus low socioeconomic position. BMC Public Health (2010) 1.27
The prospects for immunotherapy in smoking cessation. Lancet (2002) 1.27
Public health ethics theory: review and path to convergence. J Law Med Ethics (2012) 1.19
Efficacy of the nicotine vaccine 3'-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial. Addiction (2014) 1.15
Nicotine vaccines to assist with smoking cessation: current status of research. Drugs (2012) 1.14
The pharmaceutical industry--prices and progress. N Engl J Med (2004) 1.12
Framing Nicotine Addiction as a "Disease of the Brain": Social and Ethical Consequences. Soc Sci Q (2011) 1.10
Therapeutic vaccines for chronic diseases: successes and technical challenges. Philos Trans R Soc Lond B Biol Sci (2011) 1.04
Vaccines targeting drugs of abuse: is the glass half-empty or half-full? Nat Rev Immunol (2011) 1.04
Vaccination against GIP for the treatment of obesity. PLoS One (2008) 1.01
Does it matter who you see to help you stop smoking? Short-term quit rates across specialist stop smoking practitioners in England. Addiction (2012) 0.99
Vaccines against nicotine. Hum Vaccin (2009) 0.99
Vaccines against nicotine: how effective are they likely to be in preventing smoking? CNS Drugs (2001) 0.99
In the name of health and illness: on some socio-political consequences of medical influence. Soc Sci Med (1975) 0.97
Efficacy of interventions to combat tobacco addiction: Cochrane update of 2013 reviews. Addiction (2014) 0.95
Scientific tools, fake treatments, or triggers for psychological healing: how clinical trial participants conceptualise placebos. Soc Sci Med (2012) 0.95
Enhancing Children against Unhealthy Behaviors-An Ethical and Policy Assessment of Using a Nicotine Vaccine. Public Health Ethics (2013) 0.94
Nicotine vaccines for smoking cessation. Cochrane Database Syst Rev (2012) 0.93
Niccine®, a nicotine vaccine, for relapse prevention: a phase II, randomized, placebo-controlled, multicenter clinical trial. Nicotine Tob Res (2013) 0.93
From bioethics to a sociology of bio-knowledge. Soc Sci Med (2013) 0.92
'Every space is claimed': smokers' experiences of tobacco denormalisation. Sociol Health Illn (2010) 0.92
Epidemiology and social justice in light of social determinants of health research. Bioethics (2009) 0.92
Equity impact of European individual-level smoking cessation interventions to reduce smoking in adults: a systematic review. Eur J Public Health (2014) 0.89
Tobacco control funding for low-income and middle-income countries in a time of economic hardship. Tob Control (2014) 0.89
Ending versus controlling versus employing addiction in the tobacco-caused disease endgame: moral psychological perspectives. Tob Control (2013) 0.88
Ethical and policy issues in using vaccines to treat and prevent cocaine and nicotine dependence. Curr Opin Psychiatry (2011) 0.86
Would vaccination against nicotine be a cost-effective way to prevent smoking uptake in adolescents? Addiction (2012) 0.83
The relationship between socioeconomic status and 'hardcore' smoking over time--greater accumulation of hardened smokers in low-SES than high-SES smokers. Tob Control (2014) 0.82
The pharmaceuticalization of sexual risk: vaccine development and the new politics of cancer prevention. Soc Sci Med (2013) 0.82
Development of an integrated tobacco endgame strategy. Tob Control (2013) 0.82
Ethical concerns in tobacco control nonsmoker and "nonnicotine" hiring policies: the implications of employment restrictions for tobacco control. Am J Public Health (2012) 0.82
Environmental justice and health practices: understanding how health inequities arise at the local level. Sociol Health Illn (2013) 0.81
The efficacy and safety of a nicotine conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial. BMC Public Health (2012) 0.81
Widening educational inequalities in adolescent smoking following national tobacco control policies in the Netherlands in 2003: a time-series analysis. Addiction (2014) 0.81
Effectiveness of a national reimbursement policy and accompanying media attention on use of cessation treatment and on smoking cessation: a real-world study in the Netherlands. Tob Control (2014) 0.80
The importance of tobacco research focusing on marginalized groups. Addiction (2014) 0.80
Constructing a trial as a personal lifestyle change project: participants' experiences in a clinical study for nicotine vaccination. Soc Sci Med (2013) 0.78
Ethical tensions in dealing with noncommunicable diseases globally. Bull World Health Organ (2012) 0.76
Vaccination against smoking: an annotated agenda for debate. A review of scientific journals, 2001-13. Addiction (2014) 0.76
Shots for tots? Hastings Cent Rep (2013) 0.76